Anna H. Larsson

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition.

Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition.

Journal: Oncoimmunology

Published: June 26, 2019

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas.

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas.

Journal: Scientific reports

Published: March 18, 2019

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.

Journal: Journal of translational medicine

Published: May 04, 2018

Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis.

Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis.

Journal: Oncoimmunology

Published: January 22, 2018

The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.

The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.

Journal: International journal of cancer

Published: February 28, 2017

Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.

Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.

Journal: BMC clinical pathology

Published: February 23, 2016

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.

Journal: Journal of translational medicine

Published: October 07, 2015

Water soluble contrast enema examination of the integrity of the rectal anastomosis prior to loop ileostomy reversal may be superfluous.

Water soluble contrast enema examination of the integrity of the rectal anastomosis prior to loop ileostomy reversal may be superfluous.

Journal: International journal of colorectal disease

Published: December 23, 2014

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.

Journal: Diagnostic pathology

Published: April 09, 2013

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.

Journal: BMC cancer

Published: December 07, 2011

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.

Journal: British journal of cancer

Published: August 11, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026